Content
77%Reviews the quality of instructions and guidance provided to agents. Good implementation is clear, handles edge cases, and produces reliable results.
A well-structured, actionable lipidomics pipeline with concrete tool calls, a clear phased workflow, and error-recovery guidance. Its main weaknesses are a verbose conceptual opening and a monolithic single-file layout where large reference tables could be split out.
Suggestions
Tighten the 'Reasoning Strategy' paragraph by trimming biological explanations Claude already knows; keep the specific m/z values, KEGG IDs, and enzyme-disease mappings that earn their tokens.
Move the 8-row KEGG pathway table and the disease-context reference material into a references/ file (e.g., PATHWAYS.md) and link to it from SKILL.md to improve progressive disclosure.
Add an explicit validation gate in Phase 4 (e.g., assert changed-lipid categories resolve to LIPID MAPS IDs before enrichment) so the batch analysis has a clear validate→fix→retry checkpoint.
| Dimension | Reasoning | Score |
|---|---|---|
Conciseness | Mostly efficient domain reference, but the opening 'Reasoning Strategy' paragraph explains biology concepts (m/z fragments, category-to-context mappings) at length that could be tightened. | 2 / 3 |
Actionability | Provides executable tool calls with concrete parameters (e.g., LipidMaps_search_by_name(query="ceramide")) and a runnable pandas/scipy enrichment script that is copy-paste ready. | 3 / 3 |
Workflow Clarity | The Phase 0–4 pipeline is clearly sequenced with a diagram, and Phase 0 includes explicit error-recovery feedback loops (search fails → try PubChem; species abbreviations return 0 results → use generic class name). | 3 / 3 |
Progressive Disclosure | Well-sectioned single file, but ~170 lines with a large inline 8-row pathway reference table and no external reference files to split detailed material into. | 2 / 3 |
Total | 10 / 12 Passed |